Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04367389
Other study ID # ms bewegt 2.0
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 1, 2019
Est. completion date July 30, 2020

Study information

Verified date April 2021
Source University of Erlangen-Nürnberg
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the study is to evaluate the effects of a 12-week internet-based exercise and physical activity promotion intervention on physical activity. Furthermore, effects on symptoms of Multiple Sclerosis, Physical Activity-related Health Competence (PAHCO), self-concordance and basic needs satisfaction as well as usability and acceptability of the intervention will be investigated.


Recruitment information / eligibility

Status Completed
Enrollment 62
Est. completion date July 30, 2020
Est. primary completion date July 30, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - diagnosed Multiple Sclerosis (McDonald criteria) - Expanded Disability Status Scale between 0 - 6.5 - neurologically stable (no exacerbation within 30 days prior to enrollment) - internet access (WiFi) - basic knowledge on handling personal computer and the internet - owning a smartphone with the operating system Android or IOS and with access to Google Play Store or Apple App score - basic computer and internet skills (e. g. using web browser and webcams) - ability to operate a smartphone (especially to install mobile applications) - ability to read, write and comprehend as well as communicate electronically Exclusion Criteria: - regularly physically active (more than 30 minutes twice a week with at least moderate intensity; includes aerobic training, resistance training and other sports e.g. Tennis; excludes physiotherapy, physical activity during work or household, grocery shopping, gardening, walking the dog etc.) - clinically relevant cardiovascular diseases - cortisone therapy in the last 30 days - cognitive impairment that hampers study implementation - severe impairment of hand function (ataxia or paresis impeding the use of a smartphone app or smartwatch) - severe internal, orthopaedic and metabolic diseases that restrict mobility

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Physical activity promotion
Physical activity promotion activities consist of two phone or video calls with a therapists, two group video calls with a therapist, a complementary e-learning course and a fitness tracker that was provided.
Exercise
Participants will agree with their therapist on an exercise plan (endurance and resistance training) that will be made available through the studies mobile app. Frequency and duration of endurance and strength training shall be prescribed in accordance with exercise guidelines for persons with MS. However, they can be adjusted according to participants prior physical activity level and their time for exercise during the week.

Locations

Country Name City State
Germany Neurological Rehabilitation Center Quellenhof Bad Wildbad
Germany Friedrich-Alexander University Erlangen-Nürnberg Erlangen
Germany Kliniken Schmieder Konstanz Konstanz
Germany Facharztpraxis für Neurologie und Psychiatrie Dr. med Wolfgang Mattes und Andreas Stockert Pforzheim
Germany Fachklinik für Neurologie Dietenbronn GmbH Schwendi
Germany E/M/S/A - Zentrum für Neurologie/Psychiatrie/Neuroradiologie Singen
Germany Klinikum Stuttgart Katharinenhospital Stuttgart
Germany Neurologisch-Psychiatrische Praxis Dr. Weber Stuttgart
Germany Klinikum Würzburg Mitte gGmbH Würzburg

Sponsors (8)

Lead Sponsor Collaborator
University of Erlangen-Nürnberg Aktion Multiple Sklerose Erkrankter, Landesverband der DMSG in Baden-Württemberg (AMSEL) e.V., Center for Telemedicine Bad Kissingen (ZTM), Klinikum Würzburg Mitte GmbH, Medi train - Zentrum für Gesundheitssport, Sport- und Physiotherapie, motionNET systems Limited, Neurological Rehabilitation Center Quellenhof, proMX GmbH Nürnberg

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in objectively measures physical activity The physical activity level of participants is measured over a 7 day period with the accelerometer Actigraph GT3X+. The Actigraph GT3X+ measures acceleration on three axes. Steps per day, physical activity per day (activity counts) and time in moderate and vigorous physical activity per day will be calculated. Baseline, after 3 months, after 6 months
Secondary Changes in subjectively measured physical activity: BSA-Questionnaire The questionnaire asks for physical activities during a typical week. It differentiates between leisure-time/transportation activities (physical activity score) and sport-/exercise-related activities (sports score). Participants are required to report frequency and duration of activities executed during the last two weeks. Minutes of leisure-time physical activity per week and sport-/exercise related activity per week are calculated to get the physical activity and the sports score. Both scores can combined in order to receive the overall volume of physical activity completed during leisure-time and transportation as well as sport-/exercise-related activities. Baseline, after 3 months, after 6 months
Secondary Würzburger Fatigue Inventory for MS (WEIMuS) This questionnaire contains 17 items that form a physical and cognitive subscale. The total score ranges from zero to a maximum of 68 points (maximum fatigue). The cut-off value for the presence of fatigue is above 32. Baseline, after 3 months, after 6 months
Secondary Allgemeine Depressionsskala (ADS-L) German version of the Center for Epidemiologic Studies Depression Scale, 20 item questionnaire. Each item is rated on a 4-point Likert scale. Answers are scored from 0 to 3. The scores for all items are added up to receive the total score. The total score ranges from 0 to 60 with higher scores representing higher levels of depression. Baseline, after 3 months, after 6 months
Secondary Multiple Sclerosis Walking Scale-12 12-item questionnaire measuring self reported walking ability. Each item is answered on a 5-point Likert scale. Answers are scored from 1 to 5. The scores for all items are added up to receive a total score. The total score ranges from 12 to 60 with higher scores representing higher levels of depression. As a last step the total score is transformed into the walk12-score ranging from 0 to 100 ((total score -12)/48 x 100 = walk12-score). Baseline, after 3 months, after 6 months
Secondary Multiple Sclerosis Impact Scale (MSIS-29) An disease-specific questionnaire that measures quality of life and limitations due tu multiple sclerosis on two subscales (physical impact of MS, 20 items; psychological impact of MS, 9 items).Scores for both scales are generated by summing individual item scores and transforming the sum to a 0-100 scale. Higher scores represent worse health. Baseline, after 3 months, after 6 months
Secondary Timed 25-Foot Walk Test (T25FW) The task is to walk a 25foot distance as fast as possible. This test measures the functionality of the lower extremity and the walking speed. Baseline, after 3 months, after 6 months
Secondary Two-minute Walk Test (2MWT) The 2MWT measures walking endurance. It measures walking distance over 2 minutes. The subject is asked to walk as far as possible in 2 minutes. Baseline, after 3 months, after 6 months
Secondary Selbstkonkordanz-Skala (SSK-Scale) The SSK-Scale measures self-rated physical activity-related and sports-related self-concordance. It contains 12 items which are assigned to 4 subscales: intrinsic, identified, introjected and extrinsic Motivation. An overall score can be calculated based on these four subscales (minimal score = -10, maximal Score = +10). To receive the overall score the scores of the subscales for introjected and extrinsic motivation will be subtracted from the sum of the identified and intrinsic motivation subscales. A high total score suggest a high level of physical activity-related and sports-related self-concordance. Baseline, after 3 months, after 6 months
Secondary Physical activity-related health competence questionnaire 44-item questionnaire that measures physical activity-related health competence. The physical activity related health competence consists of three subcompetencies: movement competence (20 items; min = 0, max = 17.6), control competence (10 items; min = 0, max = 10.8), PA-related self-regulation competence (14 items; min = 0, max = 14.8). Baseline, after 3 months, after 6 months
Secondary German psychological need satisfaction in exercise scale This is a questionnaire to estimate the satisfaction of the three basic psychological needs based on self-determination theory during sports- and exercise related activities. It consists of 11 items which are assigned to 3 scales (one for each psychological need). Higher values on the scales indicate a higher needs satisfaction. Baseline, after 3 months, after 6 months
Secondary Usability and usefulness of the mobile application (meCue 2.0 questionnaire) The module usability and usefulness of the meCue 2.0 questionnaire was used. The module contains 3 items on usability and 3 items on usefulness that are answered on a 7-point Likert scale (scored from 1 to 7). In order two receive a score for usability and a score for usefulness, the mean is calculated for the items of each area. after 3 months, after 6 months
Secondary Usability and usefulness of the intervention Questionnaire including the Net Promoter Score and 45 self-developed items. Self-developed items covered willingness to pay, goal attainment, effects on physical function and wellbeing, adequacy of exercise prescription, evaluation of communication within the program, learning modules, App functions and activity trackers. after 3 months, after 6 months
See also
  Status Clinical Trial Phase
Completed NCT05528666 - Risk Perception in Multiple Sclerosis
Completed NCT03608527 - Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis N/A
Recruiting NCT05532943 - Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis Phase 1/Phase 2
Completed NCT02486640 - Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
Completed NCT01324232 - Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Phase 2
Completed NCT04546698 - 5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
Active, not recruiting NCT04380220 - Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
Completed NCT02835677 - Integrating Caregiver Support Into MS Care N/A
Completed NCT03686826 - Feasibility and Reliability of Multimodal Evoked Potentials
Recruiting NCT05964829 - Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis N/A
Withdrawn NCT06021561 - Orofacial Pain in Multiple Sclerosis
Completed NCT03653585 - Cortical Lesions in Patients With Multiple Sclerosis
Recruiting NCT04798651 - Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis N/A
Active, not recruiting NCT05054140 - Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis Phase 2
Completed NCT05447143 - Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis N/A
Recruiting NCT06195644 - Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients Phase 1
Completed NCT04147052 - iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis N/A
Completed NCT03591809 - Combined Exercise Training in Patients With Multiple Sclerosis N/A
Completed NCT03594357 - Cognitive Functions in Patients With Multiple Sclerosis
Completed NCT03269175 - BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies Phase 4